Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 35A English Dr. MONCTON NB E1E 3X3 |
Tel: | N/A |
Website: | https://www.organigram.ca |
IR: | See website |
Key People | ||
Peter Amirault Independent Chairman of the Board | Beena Goldenberg Chief Executive Officer, Director | Greg Guyatt Chief Financial Officer |
Katrina Mcfadden Chief People Officer | Megan Amber Mccrae Senior Vice President - Marketing and Communications | Nathalie Batten Senior Vice President - Operations |
Geoff Riggs Chief Information Officer | Timothy Emberg Chief Commercial Officer | Helen Martin Chief Legal Officer, Corporate Secretary |
Business Overview |
Organigram Holdings Inc. operates through its subsidiaries. The Company's major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing cannabis for patients and adult recreational consumers, as well as developing international business partnerships. It has also developed and owns a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. 10870277 Canada Inc. is a special purpose holding company for the Company. EIC is a cannabis processor of confectionary goods. |
Financial Overview |
For the three months ended 31 December 2023, OrganiGram Holdings Inc revenues totaled C$36.5M. Net loss totaled to C$15.8M. Results are not comparable due to year end change. |
Employees: | 984 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $236.09M as of Dec 31, 2023 |
Annual revenue (TTM): | $154.77M as of Dec 31, 2023 |
EBITDA (TTM): | -$105.73M as of Dec 31, 2023 |
Net annual income (TTM): | -$269.68M as of Dec 31, 2023 |
Free cash flow (TTM): | -$58.14M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 103,204,228 as of Apr 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |